Condition: Mantle Cell Lymphoma (MCL) · Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
This is a multicenter, international, open-label, single-arm phase II clinical trial designed to evaluate the activity and safety of a combination therapy with pirtobrutinib and rituximab (P-R) in treatment-naïve adult patients diagnosed with indolent clinical forms of Mantle Cell Lymphoma (MCL). The study applies a Simon's two-stage design, with an interim analysis after the first 16 patients to determine continuation based on complete remission rate (CRR) after 6 cycles.
This description comes directly from the study's public registry record.
Auxi Moreno · +34 683 636 850 · amoreno@geltamo.com
Ana María Méndez · +34 942 203 450 · administracion@geltamo.com
Always discuss trial participation with your own doctor first.
| Instituto Português de Oncologia de Lisboa Francisco Gentil | Lisbon, Lisbon District, Portugal | Recruiting |
| Unidade Local De Saude De Santa Maria E.P.E. | Lisbon, Lisbon District, Portugal | Not Yet Recruiting |
| INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. | Badalona, Barcelona, Spain | Not Yet Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Clinic de Barcelona | Barcelona, Barcelona, Spain | Recruiting |
| Institut Català d'oncologia de L'Hospitalet (ICO-L'Hospitalet) | L'Hospitalet de Llobregat, Barcelona, Spain | Not Yet Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Madrid, Spain | Recruiting |
| Clínica Universidad Navarra | Madrid, Madrid, Spain | Recruiting |
| Hospital Ramon y Cajal | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario 12 de Octubre | Madrid, Madrid, Spain | Recruiting |
| Hospital Clínico Universitario Virgen de la Arrixaca | El Palmar, Murcia, Spain | Recruiting |
| Hospital Costa del Sol | Marbella, Málaga, Spain | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07285590